1. Home
  2. CNH vs INCY Comparison

CNH vs INCY Comparison

Compare CNH & INCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNH
  • INCY
  • Stock Information
  • Founded
  • CNH 1842
  • INCY 1991
  • Country
  • CNH United Kingdom
  • INCY United States
  • Employees
  • CNH N/A
  • INCY N/A
  • Industry
  • CNH Construction/Ag Equipment/Trucks
  • INCY Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • CNH Industrials
  • INCY Health Care
  • Exchange
  • CNH Nasdaq
  • INCY Nasdaq
  • Market Cap
  • CNH 12.9B
  • INCY 13.4B
  • IPO Year
  • CNH N/A
  • INCY 1993
  • Fundamental
  • Price
  • CNH $12.81
  • INCY $68.46
  • Analyst Decision
  • CNH Buy
  • INCY Hold
  • Analyst Count
  • CNH 11
  • INCY 20
  • Target Price
  • CNH $14.91
  • INCY $73.81
  • AVG Volume (30 Days)
  • CNH 18.0M
  • INCY 2.0M
  • Earning Date
  • CNH 07-30-2025
  • INCY 07-29-2025
  • Dividend Yield
  • CNH 1.94%
  • INCY N/A
  • EPS Growth
  • CNH N/A
  • INCY N/A
  • EPS
  • CNH 0.80
  • INCY 0.10
  • Revenue
  • CNH $18,846,000,000.00
  • INCY $4,413,226,000.00
  • Revenue This Year
  • CNH N/A
  • INCY $13.29
  • Revenue Next Year
  • CNH $5.69
  • INCY $10.47
  • P/E Ratio
  • CNH $16.03
  • INCY $705.59
  • Revenue Growth
  • CNH N/A
  • INCY 17.13
  • 52 Week Low
  • CNH $9.28
  • INCY $53.56
  • 52 Week High
  • CNH $13.87
  • INCY $83.95
  • Technical
  • Relative Strength Index (RSI)
  • CNH 51.87
  • INCY 56.95
  • Support Level
  • CNH $12.64
  • INCY $67.57
  • Resistance Level
  • CNH $13.06
  • INCY $71.29
  • Average True Range (ATR)
  • CNH 0.29
  • INCY 1.98
  • MACD
  • CNH -0.01
  • INCY -0.13
  • Stochastic Oscillator
  • CNH 67.31
  • INCY 61.55

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Share on Social Networks: